TNXP—Phase-3_in fibromalgia halts_enrollment_due_to_futility: https://www.globenewswire.com/news-release/2021/07/23/2268197/28908/en/Tonix-Pharmaceuticals-Announces-Outcome-of-Interim-Analysis-of-Phase-3-RALLY-Study-of-TNX-102-SL-for-the-Management-of-Fibromyalgia.html